| __timestamp | Celldex Therapeutics, Inc. | Exelixis, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 104381000 | 189101000 |
| Thursday, January 1, 2015 | 100171000 | 96351000 |
| Friday, January 1, 2016 | 102726000 | 95967000 |
| Sunday, January 1, 2017 | 96171000 | 112171000 |
| Monday, January 1, 2018 | 66449000 | 182257000 |
| Tuesday, January 1, 2019 | 42672000 | 336964000 |
| Wednesday, January 1, 2020 | 42534000 | 547851000 |
| Friday, January 1, 2021 | 53311000 | 693716000 |
| Saturday, January 1, 2022 | 82258000 | 891813000 |
| Sunday, January 1, 2023 | 118011000 | 1044071000 |
| Monday, January 1, 2024 | 910408000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Exelixis, Inc. and Celldex Therapeutics, Inc. have demonstrated contrasting strategies in their R&D allocations. From 2014 to 2023, Exelixis has consistently increased its R&D budget, culminating in a staggering 450% growth, reaching over $1 billion in 2023. This reflects their aggressive pursuit of new therapies and market expansion. In contrast, Celldex's R&D spending has been more volatile, peaking in 2014 and 2023, with a notable dip in 2019. Despite these fluctuations, Celldex's recent 2023 expenditure marks a 12% increase from its 2014 levels, signaling a renewed focus on innovation. These trends highlight the dynamic nature of R&D investment strategies in the biotech sector, where adaptability and foresight are key to success.
Research and Development Investment: AbbVie Inc. vs Celldex Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and Exelixis, Inc.
Research and Development Expenses Breakdown: Zoetis Inc. vs Exelixis, Inc.
Intra-Cellular Therapies, Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Summit Therapeutics Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Ionis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Exelixis, Inc. and ACADIA Pharmaceuticals Inc.
Research and Development: Comparing Key Metrics for Verona Pharma plc and Celldex Therapeutics, Inc.
Analyzing R&D Budgets: Supernus Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Wave Life Sciences Ltd. and Celldex Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Amphastar Pharmaceuticals, Inc. and Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Celldex Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.